3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Withdrawn
1
Unknown
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
18
Other
5
Other hematologic neoplasm
3
Gastrointestinal
3
Lymphoid
2
Sarcoma
1
Plasma cell
1
Conditions
Multiple Myeloma
339
Neoplasms, Plasma Cell
62
Lymphoma
38
Recurrence
27
Leukemia
26
Lymphoma, Non-Hodgkin
21
Leukemia, Myeloid, Acute
20
Hodgkin Disease
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Myelodysplastic Syndromes
17
Leukemia, Lymphocytic, Chronic, B-Cell
17
Lymphoma, Follicular
16
Lymphoma, Large B-Cell, Diffuse
15
Immunoglobulin Light-chain Amyloidosis
14
Lymphoma, B-Cell, Marginal Zone
13
Hematologic Neoplasms
13
Lymphoma, Mantle-Cell
12
Burkitt Lymphoma
12
Lymphoma, Large-Cell, Immunoblastic
10
Neoplasms
8
Myeloproliferative Disorders
8
Leukemia, Myeloid, Chronic-Phase
8
Leukemia, Myeloid, Accelerated Phase
8
Blast Crisis
8
Neoplasm, Residual
7
Hematologic Diseases
7
Pancreatic Neoplasms
6
Lymphoma, T-Cell, Cutaneous
6
Lymphoma, B-Cell
6
Lung Neoplasms
6
Interventions
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Stomatitis
×
Plasma cell
×
Clear all
NCT05493800
2024-05-29
Capella
MitoImmune Therapeutics
Phase 2
Unknown
60 enrolled